Tempest Therapeutics, Inc. Financing Cash Flow
Tempest Therapeutics, Inc. (TPST) reported Financing Cash Flow of $3.45 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- Tempest Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $1.75M, a 46.08% increase year-over-year.
- Tempest Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $1.70M.
- Tempest Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $3.77M, a 79.02% decline year-over-year.
- Tempest Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $13.00K, a 99.16% decline year-over-year.
- Tempest Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $4.26M, a 82.62% decline from fiscal 2024.
- Tempest Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $24.50M, a 31.18% decline from fiscal 2023.
- Tempest Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $35.60M, a 212.22% increase from fiscal 2022.
- Tempest Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $11.40M, a 80.69% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $3.45M 10-Q · filed 2026-08-13 | $7.22M derived: sum of 3 quarters · filed 2026-08-13 | $7.23M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $1.70M 10-Q · filed 2026-05-14 | $5.46M derived: sum of 2 quarters · filed 2026-05-14 | $5.48M derived: sum of 3 quarters · filed 2026-05-14 | $6.68M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $3.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $3.78M derived: sum of 2 quarters · filed 2026-03-30 | $4.98M derived: sum of 3 quarters · filed 2026-08-13 | $4.26M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.21M derived: sum of 2 quarters · filed 2026-08-13 | $492.00K 10-Q · filed 2025-11-05 | $18.44M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $479.00K 10-Q · filed 2026-08-13 | $18.43M derived: sum of 3 quarters · filed 2026-08-13 | $19.97M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$721.00K 10-Q · filed 2026-05-14 | $17.23M derived: sum of 2 quarters · filed 2026-05-14 | $18.77M derived: sum of 3 quarters · filed 2026-05-14 | $23.33M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $17.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $19.49M derived: sum of 2 quarters · filed 2026-03-30 | $24.05M derived: sum of 3 quarters · filed 2026-03-30 | $24.50M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $1.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $6.10M derived: sum of 2 quarters · filed 2025-11-05 | $6.55M 10-Q · filed 2025-11-05 | $40.90M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | $4.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $5.01M 10-Q · filed 2025-08-11 | $39.36M derived: sum of 3 quarters · filed 2025-08-11 | $39.38M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | $450.00K 10-Q · filed 2025-05-13 | $34.80M derived: sum of 2 quarters · filed 2025-05-13 | $34.82M derived: sum of 3 quarters · filed 2025-05-13 | $36.01M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $34.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $34.37M derived: sum of 2 quarters · filed 2025-03-27 | $35.56M derived: sum of 3 quarters · filed 2025-03-27 | $35.60M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.21M derived: sum of 2 quarters · filed 2024-11-12 | $1.25M 10-Q · filed 2024-11-12 | -$3.47M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.23M 10-Q · filed 2024-08-08 | -$3.49M derived: sum of 3 quarters · filed 2024-08-08 | -$3.14M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $44.00K 10-Q · filed 2024-05-09 | -$4.68M derived: sum of 2 quarters · filed 2024-05-09 | -$4.33M derived: sum of 3 quarters · filed 2024-05-09 | $10.04M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$4.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$4.38M derived: sum of 2 quarters · filed 2024-03-19 | $10.00M derived: sum of 3 quarters · filed 2024-03-19 | $11.40M 10-K · filed 2024-03-19 | ||||
| 2022-09-30 | $350.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $14.73M derived: sum of 2 quarters · filed 2023-11-08 | $16.13M 10-Q · filed 2023-11-08 | $16.12M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $14.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $15.78M 10-Q · filed 2023-08-10 | $15.77M derived: sum of 3 quarters · filed 2023-08-10 | $18.94M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $1.40M 10-Q · filed 2023-05-10 | $1.39M derived: sum of 2 quarters · filed 2023-05-10 | $4.56M derived: sum of 3 quarters · filed 2023-05-10 | $45.52M derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $3.16M derived: sum of 2 quarters · filed 2023-03-22 | $44.12M derived: sum of 3 quarters · filed 2023-03-22 | $59.06M 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | $3.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $44.13M derived: sum of 2 quarters · filed 2022-11-08 | $59.07M 10-Q · filed 2022-11-08 | $59.10M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $40.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $55.91M 10-Q · filed 2022-08-15 | $55.94M derived: sum of 3 quarters · filed 2022-08-15 | $55.95M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $14.94M 10-Q · filed 2022-05-13 | $22.00K 10-Q · filed 2021-05-13 | $14.97M derived: sum of 2 quarters · filed 2022-05-13 | $14.98M derived: sum of 3 quarters · filed 2022-05-13 | $43.95M derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $41.00K derived: sum of 2 quarters · filed 2022-03-29 | $29.01M derived: sum of 3 quarters · filed 2022-03-29 | $34.60M 10-K · filed 2022-03-29 | $5.39M 10-K · filed 2021-03-29 | |||
| 2020-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $28.98M derived: sum of 2 quarters · filed 2021-11-10 | $34.57M 10-Q · filed 2021-11-10 | $5.45M 10-Q · filed 2020-11-09 | $61.43M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | $28.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $34.56M 10-Q · filed 2021-08-12 | $5.51M 10-Q · filed 2020-08-10 | $61.42M derived: sum of 3 quarters · filed 2021-08-12 | $61.54M derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | $5.59M 10-Q · filed 2021-05-13 | $32.45M derived: sum of 2 quarters · filed 2021-05-13 | $32.57M derived: sum of 3 quarters · filed 2021-05-13 | $32.59M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $26.86M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $26.98M derived: sum of 2 quarters · filed 2021-03-29 | $27.00M derived: sum of 3 quarters · filed 2021-03-29 | $26.94M 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | $121.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $143.00K derived: sum of 2 quarters · filed 2020-11-09 | $83.00K 10-Q · filed 2020-11-09 | $70.69M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | $22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$38.00K 10-Q · filed 2020-08-10 | $70.57M derived: sum of 3 quarters · filed 2020-08-10 | $78.27M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | -$60.00K 10-Q · filed 2020-05-08 | $70.55M derived: sum of 2 quarters · filed 2020-05-08 | $78.25M derived: sum of 3 quarters · filed 2020-05-08 | $77.73M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $70.61M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $78.31M derived: sum of 2 quarters · filed 2020-03-11 | $77.79M derived: sum of 3 quarters · filed 2020-03-11 | $77.74M 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | $7.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $7.18M derived: sum of 2 quarters · filed 2019-11-13 | $7.13M 10-Q · filed 2019-11-13 | $0.00 10-Q · filed 2018-11-09 | $2.67M derived: sum of 4 quarters · filed 2019-11-13 | |||
| 2018-06-30 | -$523.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$566.00K 10-Q · filed 2019-08-12 | $0.00 10-Q · filed 2018-08-09 | -$5.03M derived: sum of 3 quarters · filed 2019-08-12 | -$5.03M derived: sum of 4 quarters · filed 2019-08-12 | |||
| 2018-03-31 | -$43.00K 10-Q · filed 2019-05-15 | $0.00 10-Q · filed 2018-05-03 | -$4.51M derived: sum of 2 quarters · filed 2019-05-15 | -$4.51M derived: sum of 3 quarters · filed 2019-05-15 | -$4.51M derived: sum of 4 quarters · filed 2019-05-15 | |||
| 2017-12-31 | -$4.46M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$4.46M derived: sum of 2 quarters · filed 2019-04-01 | -$4.46M derived: sum of 3 quarters · filed 2019-04-01 | -$4.46M 10-K · filed 2019-04-01 | $0.00 10-K · filed 2018-03-15 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $0.00 derived: sum of 2 quarters · filed 2018-11-09 | $0.00 10-Q · filed 2018-11-09 | -$7.00K derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | -$7.00K derived: sum of 3 quarters · filed 2018-08-09 | $88.00K derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-03 | -$7.00K derived: sum of 2 quarters · filed 2018-05-03 | $88.00K derived: sum of 3 quarters · filed 2018-05-03 | $54.15M derived: sum of 4 quarters · filed 2018-05-03 | ||||
| 2016-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $88.00K derived: sum of 2 quarters · filed 2018-03-15 | $54.15M derived: sum of 3 quarters · filed 2018-03-15 | $54.15M 10-K · filed 2018-03-15 | ||||
| 2016-09-30 | $95.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $54.16M derived: sum of 2 quarters · filed 2017-11-02 | $54.16M 10-Q · filed 2017-11-02 | $54.03M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2016-06-30 | $54.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $54.06M 10-Q · filed 2017-08-03 | $53.94M derived: sum of 3 quarters · filed 2018-03-15 | $54.02M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-09 | -$122.00K derived: sum of 2 quarters · filed 2018-03-15 | -$42.00K derived: sum of 3 quarters · filed 2018-03-15 | $599.00K derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2015-12-31 | -$122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$42.00K derived: sum of 2 quarters · filed 2018-03-15 | $599.00K derived: sum of 3 quarters · filed 2018-03-15 | $125.39M 10-K · filed 2018-03-15 | ||||
| 2015-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $721.00K derived: sum of 2 quarters · filed 2016-11-03 | $125.51M 10-Q · filed 2016-11-03 | $125.67M derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2015-06-30 | $641.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $125.43M 10-Q · filed 2016-08-04 | $125.59M derived: sum of 3 quarters · filed 2017-03-02 | $125.50M derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2015-03-31 | $124.79M 10-Q · filed 2016-05-05 | $124.94M derived: sum of 2 quarters · filed 2017-03-02 | $124.86M derived: sum of 3 quarters · filed 2017-03-02 | |||||
| 2014-12-31 | $158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $73.00K derived: sum of 2 quarters · filed 2017-03-02 | $51.71M 10-K · filed 2017-03-02 | |||||
| 2014-09-30 | -$85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $51.55M 10-Q · filed 2015-11-05 | ||||||
| 2014-06-30 | $51.64M 10-Q · filed 2015-08-10 | |||||||
| 2013-12-31 | $32.41M 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |